<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://synergbiopharma.com/sitemaps_xsl.xsl"?><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url>
<loc>https://synergbiopharma.com/infographic/</loc>
</url>
<url>
<loc>https://synergbiopharma.com/infographic/understanding-the-stakes-of-ind-submissions-why-timely-approvals-matter/</loc>
<lastmod>2026-09-04T09:35:47-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2025/10/syner-g-infographic-Understanding-the-Stakes-of-Ind-Submissions-Why-Timely-Submissions-Matter-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/accelerating-the-delivery-of-advanced-therapies/</loc>
<lastmod>2026-09-04T09:32:33-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/02/syner-g-Accelerating-the-Delivery-of-Advanced-Therapies.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/early-cmc-decisions-that-shape-ind-readiness/</loc>
<lastmod>2026-09-04T09:30:28-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/02/synerg-Early-CMC-Decisions-that-Shape-IND-Readiness.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/common-hurdles-sponsors-face-upon-a-marketing-application-submission/</loc>
<lastmod>2026-09-04T09:29:40-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/03/synerg-Common-Hurdles-Sponsors-Face-upon-a-Marketing-Application-Submission.png?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/what-you-should-know-about-the-fdas-new-cnpv-pilot-program/</loc>
<lastmod>2026-09-04T09:28:56-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/03/What-You-Should-Know-About-FDAs-New-CNPV-Pilot-Program.png?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/from-discovery-to-approval/</loc>
<lastmod>2026-09-04T09:27:09-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/04/Group-156.png?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/rethinking-toxicology-smarter-paths-beyond-animal-testing/</loc>
<lastmod>2026-09-04T09:26:16-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/06/Rethinking-Toxicology.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/navigating-the-regulatory-crossroads-of-drug-device-and-biologic/</loc>
<lastmod>2026-09-04T09:24:51-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/07/A-regulatory-roadmap.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/everyone-is-talking-about-ai-few-are-scaling-it/</loc>
<lastmod>2026-09-04T09:23:57-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2026/07/syner.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/mastering-quality-control-ensuring-excellence-in-medical-writing/</loc>
<lastmod>2026-08-03T16:33:59-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2024/10/syner-g-infographic-Mastering-Quality-Control_-Ensuring-Excellence-in-Medical-Writing-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/the-business-case-for-investing-in-cmc-protecting-your-asset-and-ensuring-success/</loc>
<lastmod>2026-03-31T17:51:34-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2025/08/syner-g-infographic-The-Business-Case-for-Investing-in-CMC-Protecting-Your-Asset-and-Ensuring-Success-640x360-2.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/cracking-the-code-syner-gs-blueprint-for-success-with-pharmaceutical-stability-studies/</loc>
<lastmod>2026-03-06T09:49:51-05:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2025/02/syner-g-infographic-Syner-G-Blueprint-for-Success-with-Pharmaceutical-Stability-Studies-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/avoid-drug-development-derailment-infographic/</loc>
<lastmod>2026-03-06T09:42:32-05:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2024/06/syner-g-infographic-Avoid-Drug-Development-Derailment-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/case-study-highlight-how-a-medical-writing-partnership-drives-regulatory-success/</loc>
<lastmod>2026-03-06T09:25:16-05:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2025/03/syner-g-infographic-How-a-Medical-Writing-Partnership-Drives-Regulatory-Success-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/strategies-for-accelerated-cmc-development-infographic/</loc>
<lastmod>2026-03-06T01:30:12-05:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2024/06/syner-g-infographic-Strategies-for-Accelerated-CMC-Development-Infographic-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/minimize-disruption-maximize-efficiency-minimize-disruption-maximize-efficiency/</loc>
<lastmod>2026-03-06T00:34:03-05:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2025/07/syner-g-infographic-Minimize-Disruption-Maximize-Efficiency-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url>
<url>
<loc>https://synergbiopharma.com/infographic/benefits-of-orphan-drug-designation-by-the-numbers-infographic/</loc>
<lastmod>2025-10-20T21:12:43-04:00</lastmod>
<image:image>
<image:loc><![CDATA[https://ejdoqu69omg.exactdn.com/wp-content/uploads/2024/06/syner-g-infographic-Benefits-or-Orphan-Drug-Designation-by-the-Numbers-640x360-1.jpg?strip=all]]></image:loc>
</image:image></url></urlset>
